FR2657885B1 - - Google Patents

Info

Publication number
FR2657885B1
FR2657885B1 FR9001462A FR9001462A FR2657885B1 FR 2657885 B1 FR2657885 B1 FR 2657885B1 FR 9001462 A FR9001462 A FR 9001462A FR 9001462 A FR9001462 A FR 9001462A FR 2657885 B1 FR2657885 B1 FR 2657885B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9001462A
Other languages
French (fr)
Other versions
FR2657885A1 (fr
Inventor
Serge Michel
Jacques Bailly
Gaelle Saintigny
Uwe Reichert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Centre International de Recherches Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre International de Recherches Dermatologiques Galderma filed Critical Centre International de Recherches Dermatologiques Galderma
Priority to FR9001462A priority Critical patent/FR2657885A1/fr
Priority to DE4103727A priority patent/DE4103727A1/de
Priority to GB9102616A priority patent/GB2241702B/en
Priority to US07/652,073 priority patent/US5312751A/en
Priority to JP3037682A priority patent/JPH078290A/ja
Publication of FR2657885A1 publication Critical patent/FR2657885A1/fr
Priority to US08/231,145 priority patent/US5541073A/en
Application granted granted Critical
Publication of FR2657885B1 publication Critical patent/FR2657885B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6845Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a cytokine, e.g. growth factors, VEGF, TNF, a lymphokine or an interferon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
FR9001462A 1990-02-08 1990-02-08 Anticorps capables de reconnaitre specifiquement un antigene du stratum corneum de l'epiderme humain, leur preparation et leur application, notamme comme vecteurs de drogues. Granted FR2657885A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9001462A FR2657885A1 (fr) 1990-02-08 1990-02-08 Anticorps capables de reconnaitre specifiquement un antigene du stratum corneum de l'epiderme humain, leur preparation et leur application, notamme comme vecteurs de drogues.
DE4103727A DE4103727A1 (de) 1990-02-08 1991-02-07 Zur spezifischen erkennung eines antigens des stratum corneum der menschlichen epidermis befaehigte antikoerper, ihre herstellung und ihre anwendung, insbesondere als traeger von arzneimittelwirkstoffen
GB9102616A GB2241702B (en) 1990-02-08 1991-02-07 Antibodies which bind to the stratum corneun and their use as drug vectors
US07/652,073 US5312751A (en) 1990-02-08 1991-02-07 Hybridoma producing a monoclonal antibody specific for an antigen of the stratum corneum of human epidermis
JP3037682A JPH078290A (ja) 1990-02-08 1991-02-08 ヒト表皮角質層の抗原を特異的に認識することができる抗体,その調製およびそれを使用する方法
US08/231,145 US5541073A (en) 1990-02-08 1994-04-22 Method of diagnosing epidermis differentiation disorders in a patient using a stratum corneum-specific antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9001462A FR2657885A1 (fr) 1990-02-08 1990-02-08 Anticorps capables de reconnaitre specifiquement un antigene du stratum corneum de l'epiderme humain, leur preparation et leur application, notamme comme vecteurs de drogues.

Publications (2)

Publication Number Publication Date
FR2657885A1 FR2657885A1 (fr) 1991-08-09
FR2657885B1 true FR2657885B1 (US08197722-20120612-C00042.png) 1995-01-13

Family

ID=9393498

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9001462A Granted FR2657885A1 (fr) 1990-02-08 1990-02-08 Anticorps capables de reconnaitre specifiquement un antigene du stratum corneum de l'epiderme humain, leur preparation et leur application, notamme comme vecteurs de drogues.

Country Status (5)

Country Link
US (2) US5312751A (US08197722-20120612-C00042.png)
JP (1) JPH078290A (US08197722-20120612-C00042.png)
DE (1) DE4103727A1 (US08197722-20120612-C00042.png)
FR (1) FR2657885A1 (US08197722-20120612-C00042.png)
GB (1) GB2241702B (US08197722-20120612-C00042.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288215B1 (en) 1996-08-30 2001-09-11 Auburn University Monoclonal antibodies specific to cooked meats
AU4094297A (en) 1996-08-30 1998-03-19 Auburn University Monoclonal antibodies specific to cooked meats
US20090098076A1 (en) * 2005-11-24 2009-04-16 Basf Se Method For the Production of a Keratin-Binding Effector Molecule
JP2009521404A (ja) * 2005-11-24 2009-06-04 ビーエーエスエフ ソシエタス・ヨーロピア ケラチン結合ポリペプチドとカルボキシル基又はスルホン酸基を有するエフェクター分子とのカップリング方法
KR20220078843A (ko) 2020-12-04 2022-06-13 이승윤 약산성수 공급장치

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4598051A (en) * 1980-03-12 1986-07-01 The Regents Of The University Of California Liposome conjugates and diagnostic methods therewith
US4510244A (en) * 1980-04-17 1985-04-09 The Board Of Trustees Of The Leland Stanford Jr. University Cell labeling with antigen-coupled microspheres
US4668638A (en) * 1983-03-24 1987-05-26 The Liposome Company, Inc. Liposome composition for lupus assay
US4649115A (en) * 1983-03-31 1987-03-10 Sloan-Kettering Institute Monoclonal antibodies to skin cells
FR2606033B1 (fr) * 1986-10-31 1988-12-16 Cird Proteine cytoplasmique des cellules suprabasales de l'epiderme, anticorps capables de reconnaitre cette proteine, et lignees cellulaires hybrides capables de secreter de tels anticorps
FR2606034B1 (fr) * 1986-10-31 1989-06-02 Cird Nouvelle proteine de surface des cellules basales de l'epiderme, anticorps capables de reconnaitre cette proteine, et leur utilisation, et lignees cellulaires hybrides capables de secreter de tels anticorps

Also Published As

Publication number Publication date
DE4103727A1 (de) 1991-08-14
JPH078290A (ja) 1995-01-13
FR2657885A1 (fr) 1991-08-09
US5541073A (en) 1996-07-30
GB2241702B (en) 1994-08-24
US5312751A (en) 1994-05-17
GB9102616D0 (en) 1991-03-27
GB2241702A (en) 1991-09-11

Similar Documents

Publication Publication Date Title
FR2667367B1 (US08197722-20120612-C00042.png)
FR2665991B1 (US08197722-20120612-C00042.png)
DE4191444T (US08197722-20120612-C00042.png)
DE4092522T (US08197722-20120612-C00042.png)
EP0684733A3 (US08197722-20120612-C00042.png)
DE4192975T (US08197722-20120612-C00042.png)
DE4192244T (US08197722-20120612-C00042.png)
FR2668278B1 (US08197722-20120612-C00042.png)
FR2657011B1 (US08197722-20120612-C00042.png)
EP0464227A4 (US08197722-20120612-C00042.png)
FR2657885B1 (US08197722-20120612-C00042.png)
FR2658666B1 (US08197722-20120612-C00042.png)
DE4191864T1 (US08197722-20120612-C00042.png)
IN171185B (US08197722-20120612-C00042.png)
ECSM90396U (US08197722-20120612-C00042.png)
ECSM90423U (US08197722-20120612-C00042.png)
ECSM90470U (US08197722-20120612-C00042.png)
IN171814B (US08197722-20120612-C00042.png)
IN174471B (US08197722-20120612-C00042.png)
IN175178B (US08197722-20120612-C00042.png)
IN175568B (US08197722-20120612-C00042.png)
IN176077B (US08197722-20120612-C00042.png)
ECSM90514U (US08197722-20120612-C00042.png)
EP0457330A3 (US08197722-20120612-C00042.png)
AU7590191A (US08197722-20120612-C00042.png)

Legal Events

Date Code Title Description
ST Notification of lapse